id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-0268-0002,FDA,FDA-2015-D-0268,"Individual Patient Expanded Access Applications: Form FDA 3926; Draft
Guidance for Industry",Other,Guidance,2015-02-10T05:00:00Z,2015,2,2015-02-10T05:00:00Z,2015-02-11T04:59:59Z,2025-09-26T09:00:34Z,,1,0,09000064819fc702
FDA-2015-D-0268-0001,FDA,FDA-2015-D-0268,"Individual Patient Expanded Access Applications: Form FDA 3926; Draft
Guidance for Industry; Availability",Rule,Final Rule with Request for Comments,2015-02-10T05:00:00Z,2015,2,2015-02-10T05:00:00Z,2015-04-14T03:59:59Z,2021-01-19T17:31:11Z,2015-02561,0,0,09000064819fca41